Glaxosmithkline Pharma downgraded to ‘reduce’ at Angel broking | Alrroya

Glaxosmithkline Pharma downgraded to ‘reduce’ at Angel broking

Tuesday, 27 April 2010  at  10:22, Bloomberg
GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of the UK’s biggest drugmaker, was downgraded to “reduce” from “neutral” by Sarabjit Kour Nangra, an analyst at Angel Broking Ltd in Mumbai. The brokerage cited valuations for the reduction in an e-mailed note to clients today.








Your comments

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <b> <i> <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options